The DEEP project has received research funding from the European Union under the 7th Framework Programme
Work Plan
WP2 – Formulation, development and preparation of a paediatric oral solution
WP3 – Performing a single dose pharmacokinetic trial in children under six years
WP4 – Performing an efficacy/safety trial to compare deferiprone and deferasirox
WP5 – Performing a long-term safety study in paediatric patients
WP6 – Management of regulatory and pharmacoeconomic issues
